India to Saudi Arabia: Heparin Export Trade Route

The India to Saudi Arabia Heparin corridor is one of India's established pharmaceutical export routes, with 233 shipments documented worth a combined $43.5M USD. The route is dominated by GLAND PHARMA LIMITED , which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's heparin manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $186.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with heparin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 16.5%, placing it at rank #19 among India's top heparin export destinations globally.

On the import side, key buyers of Indian heparin in Saudi Arabia include BOSTON ONCOLOGY ARABIA, Boston Oncology Arabia , BOSTON ONCOLOGY ARABIA and 6 others. BOSTON ONCOLOGY ARABIA is the single largest importer with 99 shipments valued at $16.8M USD.

India's heparin exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LIMITED with 124 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LIMITED , GLAND PHARMA LTD, GLAND PHARMA LIMITED — together account for 99% of total trade value on this route. The average shipment value of $186.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as low molecular weight heparin enoxaparinsodium injection usp 40mg in 0.4ml pre-filled syringe and low molecular weight heparin enoxaparinsodium injection usp, 40mg in 0.4ml pre-filled syringe, suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BOSTON ONCOLOGY ARABIA is the largest importer with 99 shipments worth $16.8M USD — representing 39% of all heparin imports from India on this route. A total of 9 buyers are active on this corridor.